A US company that makes an experimental drug for treating the often
deadly Ebola virus said Monday it has sent all its available supplies
to West Africa.
Some 961 people have died from the hemorrhagic fever in Sierra Leone,
Liberia, Guinea and Nigeria since March during the largest Ebola
outbreak in history.
"In responding to the request received this weekend from a West
African nation, the available supply of ZMapp is exhausted," said a
statement on the Mapp Bio website.
"Any decision to use ZMapp must be made by the patients' medical
team," it said, adding that the drug was "provided at no cost in all
cases."
The biomedical collaboration between US and Canadian researchers
involves a drug that is manufactured in tobacco leaves and is hard to
produce on a large scale.
The company did not reveal which nation received the doses, or how
many were sent.
CNN reported that Liberia was to receive the sample doses.
The two American missionary workers who fell ill with Ebola while
working in Monrovia last month were given doses of the drug.
Both have been transported to an isolation unit at Emory University
Hospital in Atlanta, Georgia, where they are receiving continuous
care.
A Spanish priest who was sickened with Ebola has also been given a dose.
The ethics of distributing experimental medications to some people but
not others was the focus of a special meeting of the World Health
Organization on Monday.
The US Centers for Disease Control and Prevention has repeatedly
stressed that the drug's effects are unknown, since it has not been
through a process of rigorous clinical trials.
There is no medicine or vaccine for Ebola on the world market.
AFP
No comments:
Post a Comment